£47m +awarded
in research funding
NineDoctoral fellowships
from national funders
FivePre-doctoral fellowships
from national funders
How we create change
Clinical care
We deliver definitive trials that answer the questions patients and health care professionals actually ask. Our evidence directly changes treatment pathways and national guidelines.
Delivering value
We reduce waste in healthcare systems embedding cost effectiveness in our research. We attract major industry and research council investment, and generate intellectual property with commercial potential. https://qminnovation.co.uk/project/refleks/. Efficient trial research design is core to our work, leveraging routinely collected data to deliver answers at scale and speed.
Developing talent
We train the next generation of research leaders and act as a hub for interdisciplinary collaboration. Our people go on to lead international societies, sit on NIHR funding panels, and advise Parliament on health and social care policy. From our labs to global leadership - we shape the field.
Featured impact story: The WAX trial
Getting patients back on their feet
The Challenge
For decades, patients who had surgery for an ankle fracture were told to stay off their foot for six weeks. This meant patients needing walking aids, taking time off work and loosing their independence. We wanted to challenge the status quo to understand if this was necessary
The Evidence
*Led by Mr Christopher Bretherton and Professor Xavier Griffin, the NIHR-funded WAX trial was delivered across 23 NHS hospitals, we delivered the definitive answer, published in The Lancet (2024):*
Early, protected weight-bearing is safe, improves function, reduces time off work, and is cost-effective—with no increase in complications.
The Impact
- For Patients “I could get back to my life sooner.” Patients told us early weight-bearing restored independence.
- For the NHS - £0.9–£1.1 million estimated annual savings from reduced healthcare use. 68,000–86,000 workdays restored each year through faster recovery.
- For Clinical Practice - The British Orthopaedic Association now recommends early weight-bearing in national guidance. A 2026 national audit will measure how far practice has changed since our 2017 baseline.
- For Policy - Cited in BOA and NHS England trauma policy discussions. Planned for NICE surveillance review. An NIHR Evidence Alert (2025) has amplified findings to clinicians, commissioners, and the public.
What This Demonstrates
We delivered robust, generalisable evidence. And we are already seeing practice change at scale—across the UK and internationally.
Follow this link to read the full WAX paper
Join our Mission in advancing care for people suffering with bone, joint and movement conditions.
Partners and Investors: Drive lasting change in musculoskeletal research and care. Explore partnership opportunities with us
Collaborators: Work with our team, we welcome new academic and industry colleaborations
Future Talent: Launch and develop you research career. Find out more about fellowship opportunities here and current career opportunities here
Public & Patients: Get involved and shape our work, join our public advisory group here